Clinical evidence reveals the high expression of RPL34 in non-small-cell lung cancer (NSCLC) patient samples, and the overexpression of RPL34 has been shown to promote malignant proliferation in NSCLC cells [71]. This evidence concerns the gene RPL34 and non-small cell lung carcinoma.